
Neotract, Inc.
Free shipping on orders over $99 · 30-day returns
UroLift Advanced Tissue Control (ATC) System is an FDA 510(k)-cleared medical device (K200441) manufactured by Neotract, Inc.. This device is classified under the Gastroenterology, Urology specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on June 4, 2020. Regulation: 8.